Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1929 1
1945 3
1946 1
1947 5
1948 6
1949 5
1950 10
1951 14
1952 5
1953 14
1954 27
1955 19
1956 19
1957 11
1958 16
1959 28
1960 22
1961 17
1962 20
1963 48
1964 80
1965 48
1966 65
1967 104
1968 103
1969 116
1970 102
1971 120
1972 157
1973 114
1974 115
1975 95
1976 96
1977 94
1978 110
1979 109
1980 116
1981 105
1982 138
1983 158
1984 148
1985 190
1986 172
1987 180
1988 213
1989 259
1990 264
1991 251
1992 285
1993 329
1994 437
1995 469
1996 413
1997 507
1998 559
1999 548
2000 578
2001 586
2002 542
2003 605
2004 707
2005 750
2006 896
2007 918
2008 1102
2009 1361
2010 1605
2011 1848
2012 2179
2013 2368
2014 2673
2015 2969
2016 3059
2017 3342
2018 3479
2019 3771
2020 4046
2021 4579
2022 4471
2023 4312
2024 4540
2025 5144
2026 2137

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65,393 results

Results by year

Filters applied: . Clear all
Page 1
Modeling blood-brain barrier-glioblastoma interactions: implications for chemoresistance and therapeutic targeting.
Ammar MAN, Dobiasova S, Salaroglio IC, Hmissa S, Missaoui N, Riganti C. Ammar MAN, et al. Fluids Barriers CNS. 2026 May 12. doi: 10.1186/s12987-026-00816-3. Online ahead of print. Fluids Barriers CNS. 2026. PMID: 42120978 Review.
Glioblastoma (GBM) is the most aggressive and common primary brain tumor in adults and remains associated with a dismal prognosis despite standard-of-care treatment. ...
Glioblastoma (GBM) is the most aggressive and common primary brain tumor in adults and remains associated with a dismal prognosis des …
Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial.
Garfinkle EAR, Perales-Linares R, Gimple RC, Livingstone AJ, Roberts KF, Butt OH, Goedegebuure SP, McLellan MD, Chang GS, Hundal J, Yan J, Navarro JB, Paxton SA, Chattopadhyay S, Cooch N, Perales-Puchalt A, Stavroulaki K, Rochestie S, Peters J, Junker B, Campian JL, Chheda MG, Chicoine MR, Kim AH, Willie JT, Zipfel GJ, Dowling JL, Miller CA, Griffith OL, Griffith M, Gillanders WE, Miller KE, Mardis ER, Sardesai NY, Dunn GP, Johanns TM. Garfinkle EAR, et al. Nat Cancer. 2026 May 12. doi: 10.1038/s43018-026-01163-w. Online ahead of print. Nat Cancer. 2026. PMID: 42120910
Glioblastoma is a fatal disease with a median prognosis of 12-18 months. Recent studies have shown encouraging results using neoantigen-based vaccines to stimulate glioblastoma-directed immune responses, but overall immunogenicity has been low. ...This study met the …
Glioblastoma is a fatal disease with a median prognosis of 12-18 months. Recent studies have shown encouraging results using neoantig …
Integrative bioinformatics analysis unveils neuro-cancer crosstalk-related genes and establishes prognostic risk model in Glioblastoma.
Zeng L, Li D, Du M, Wu T, Liao Y, Huang Y, Liao X. Zeng L, et al. Sci Rep. 2026 May 12. doi: 10.1038/s41598-026-51730-5. Online ahead of print. Sci Rep. 2026. PMID: 42120472
Neuro-cancer crosstalk plays an important role in the development and progression of Glioblastoma (GBM), but its specific mechanisms remain incompletely elucidated. This study aims to systematically identify key genes related to neuro-cancer crosstalk in GBM and construct …
Neuro-cancer crosstalk plays an important role in the development and progression of Glioblastoma (GBM), but its specific mechanisms …
From anthelmintic to neuro-oncology: A systematic review of mebendazole repurposing for brain tumour therapy.
Blum CB, McMenamin M, Khoo T, Edwin JM, Jose P, O'Callaghan LA. Blum CB, et al. Br J Clin Pharmacol. 2026 May 12. doi: 10.1002/bcp.70565. Online ahead of print. Br J Clin Pharmacol. 2026. PMID: 42120351 Review.
A total of 22 studies were included (17 preclinical and five clinical/population). RESULTS: Preclinical work across glioblastoma, diffuse midline glioma, medulloblastoma and meningioma demonstrates consistent tumour growth suppression and survival extension via microtubule …
A total of 22 studies were included (17 preclinical and five clinical/population). RESULTS: Preclinical work across glioblastoma, dif …
Application of 200 kHz Tumor Treating Fields (TTFields) in Patients With Infratentorial High-Grade Glioma: Case Series.
Kamiya-Matsuoka C, Patel CB, Battiste JD. Kamiya-Matsuoka C, et al. Brain Tumor Res Treat. 2026 Apr;14(2):109-108. doi: 10.14791/btrt.2025.0038. Brain Tumor Res Treat. 2026. PMID: 42120300
Tumor treating fields (TTFields) therapy at 200 kHz is FDA-approved for supratentorial glioblastoma. However, reports of TTFields in patients with infratentorial high-grade glioma (HGG) are rare. ...
Tumor treating fields (TTFields) therapy at 200 kHz is FDA-approved for supratentorial glioblastoma. However, reports of TTFields in …
Testosterone-TGF-beta crosstalk modulates cell migration in human glioblastoma-derived cell lines.
Alemán OR, Quintero JC, Hernández-Lúa LN, Espejel-Nuñez A, Camacho-Arroyo I. Alemán OR, et al. Steroids. 2026 May 10:109798. doi: 10.1016/j.steroids.2026.109798. Online ahead of print. Steroids. 2026. PMID: 42119662
Glioblastoma (GB) is the most aggressive brain tumor due to its extensive cellular migration. ...
Glioblastoma (GB) is the most aggressive brain tumor due to its extensive cellular migration. ...
Targeting dihydroorotate dehydrogenase (hDHODH) beyond the barrier: discovery of MEDS700 as blood-brain barrier permeable hDHODH inhibitor.
Sainas S, Vigato C, Circosta P, Zonfrillo M, Servidei T, Alberti M, Rescigno M, Miggiano R, Gaidano V, Vitale N, Passoni A, Lanno A, Buccinnà B, Piccinini M, Lorenzati M, Gentile S, Sferrazza G, Sgambato A, Saglio G, Giorgis M, Boschi D, Lolli ML. Sainas S, et al. Eur J Med Chem. 2026 Apr 27;314:118896. doi: 10.1016/j.ejmech.2026.118896. Online ahead of print. Eur J Med Chem. 2026. PMID: 42119261
Targeting cancer metabolism, particularly de novo nucleotide biosynthesis, has emerged as a promising and innovative therapeutic strategy for both hematologic and solid malignancies, including those of the Central Nervous System (CNS). Glioblastoma cancer stem-like cells a …
Targeting cancer metabolism, particularly de novo nucleotide biosynthesis, has emerged as a promising and innovative therapeutic strategy fo …
Gliomas as network diseases: Neuron-tumor interactions, connectome disruption, and clinical implications.
Vargas LO, Latzman S, Tickoo L, Abikenari M, Syed SA, Mittelman L, Cassimatis N, Teng CL, Sistiaga IL, D'Amico RS. Vargas LO, et al. Clin Neurol Neurosurg. 2026 May 11;267:109475. doi: 10.1016/j.clineuro.2026.109475. Online ahead of print. Clin Neurol Neurosurg. 2026. PMID: 42119240 Review.
Connectome-derived metrics have been associated with tumor grade, molecular subtype, recurrence, cognitive outcomes, and survival. In selected glioblastoma cohorts, preserved intratumoral functional connectivity may correlate with improved outcomes, suggesting a marker of …
Connectome-derived metrics have been associated with tumor grade, molecular subtype, recurrence, cognitive outcomes, and survival. In select …
65,393 results
You have reached the last available page of results. Please see the User Guide for more information.